Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 68

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 68
---
 to solicit offers to purchase the securities offered pursuant to
this prospectus on a reasonable best efforts basis. The engagement agreement does not give rise to any commitment by the placement agent
to purchase any of our securities, and the placement agent will have no authority to bind us by virtue of the engagement agreement. The
placement agent is not purchasing or selling any of the securities offered by us under this prospectus, nor is it required to arrange
for the purchase or sale of any specific number or dollar amount of securities. This is a best-efforts offering and there is no minimum
offering amount required as a condition to the closing of this offering. The placement agent has agreed to use reasonable best efforts
to arrange for the sale of the securities by us. Therefore, we may not sell all of the shares of common stock, Pre-Funded Warrants and
Warrants being offered. The terms of this offering are subject to market conditions and negotiations between us, the placement agent and
prospective investors. The placement agent does not guarantee that it will be able to raise new capital in any prospective offering. The
placement agent may engage sub-agents or selected dealers to assist with the offering.

Investors purchasing
securities offered hereby will have the option to execute a securities purchase agreement with us. In addition to rights and remedies
available to all purchasers in this offering under federal securities and state law, the purchasers which enter into a securities purchase
agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract is
material to larger purchasers in this offering as a means to enforce the following covenants uniquely available to them under the securities
purchase agreement: (i) a covenant to not enter into variable rate financings for a period of one year following the closing
of the offering, subject to an exception; and (ii) a covenant to not enter into any equity financings for 90 days from
closing of the offering, subject to certain exceptions. The nature of the representations, warranties and covenants in the securities
purchase agreements include:

| ● | standard issuer representations and warranties on matters such as organization, qualification, authorization, no conflict, no governmental filings required, current in SEC filings, no litigation, labor or other compliance issues, environmental, intellectual property and title matters and compliance with various laws such as the Foreign Corrupt Practices Act; and |

| ● | covenants regarding matters such as registration of Warrant shares, no integration with